Director of the technical unit against the Kovid-19 of the World Health Organization (WHO), Maria Van Kerkhov, at a press conference today highlighted that the unit had not found any evidence that the version Coronavirus Sars-CoV-2, first identified in South Africa, is more lethal than others.
There is also no evidence that it causes a greater number of severe cases of the disease or is more difficult to diagnose.
Van Kerakhov announced, “An increase in personal capacity has been identified, as seen in UK variants.”
Another aspect detected by the WHO is that vaccines from manufacturers such as Johnson & Johnson, Novavex and AstraZeneca are less effective against this version, according to the organization, revealed in about 50 countries.
Kate O’Brien, director of the WHO vaccination program, stated that clinical trials with the AstraZeneca vaccine during the circulation period of this variant were performed with a small number of patients and did not include anyone who was severely affected by Kovid-19 Was ill
“This is important because what we are seeing is that all vaccines are more effective with people who have serious illnesses,” the epidemiologist said.
Experts point out that despite differences in South Africa from other strains, South Africa has shown that, with the right public health measures, it can be controlled.
